Coronary Artery Disease and Myocardial Infarction

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 1h 35m 42s (16 videos)

Dian Sidik Arsyad , Steven HJ Hageman , Nurul Qalby , et al

Read time: 18m
ESC 23: LIBerate-HeFH Study

Frederick Raal,

Watch time: 4m 16s
ESC 23: The ILUMIEN IV Trial

Ziad A Ali,

Watch time: 4m 12s
ESC 23: OCEAN(a)-DOSE Trial Update

Michelle O'Donoghue,

Watch time: 3m 22s
ESC 23: LODESTAR Trial

Myeong-Ki Hong,

Watch time: 3m 42s

Yan Yan, Gilles Montalescot, Mathieu Kerneis, et al

Watch time: 5h 59m 38s (60 videos)
ACC 23: Lipid Management & the CLEAR Trial with Dr Michos

Erin D Michos,

Watch time: 5m 34s
View from the Thoraxcenter: ACC.23 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 33m 36s
ACC 23: MK-0616: Oral PCSK9 inhibitor In Hypercholesterolemia Patients

Christie Ballantyne,

Watch time: 3m 44s
ACC 23: Effect of Evolocumab on Coronary Plaque Morphology: The YELLOW III Study

Annapoorna Kini ,

Watch time: 8m 1s
ACC.23 Late-Breaker Discussion: The CLEAR-Outcomes Trial

Harriette Van Spall, Steven E Nissen,

Watch time: 16m 12s

Yan Yan, Gilles Montalescot, Mathieu Kerneis, et al

Watch time: 5h 59m 38s (60 videos)

Yoshiyasu Minami , Daisuke Kinoshita , Yusuke Muramatsu , et al

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 1h 35m 42s (16 videos)
ACC.23 Late-Breaker Discussion: The CLEAR-Outcomes Trial

Harriette Van Spall, Steven E Nissen,

Watch time: 16m 12s
ACC 23: Effect of Evolocumab on Coronary Plaque Morphology: The YELLOW III Study

Annapoorna Kini ,

Watch time: 8m 1s

Dinakar Bootla , Pruthvi C Revaiah , Navjyot Kaur , et al

Read time: 11 minutes
View from the Thoraxcenter: What's Hot at ACC.23?

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 22m 4s
ESC 23: The ILUMIEN IV Trial

Ziad A Ali,

Watch time: 4m 12s
ESC 23: LODESTAR Trial

Myeong-Ki Hong,

Watch time: 3m 42s
View from the Thoraxcenter: ACC.23 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 33m 36s
EP 78: Your Guide to Lipoprotein(a) with Dr. Salim S Virani

Salim S Virani, Ankur Kalra,

Listen time: 46m 28s
Radcliffe & CardioNerds @AHA22: Reduction of Triglycerides With Pemafibrate

Aruna D Pradhan, Gurleen Kaur,

Watch time: 14m 20s

Media

Yan Yan, Gilles Montalescot, Mathieu Kerneis, et al

Watch time: 5h 59m 38s (60 videos)
ESC 23: OCEAN(a)-DOSE Trial Update

Michelle O'Donoghue,

Watch time: 3m 22s
ESC 23: LODESTAR Trial

Myeong-Ki Hong,

Watch time: 3m 42s
ESC 23: LIBerate-HeFH Study

Frederick Raal,

Watch time: 4m 16s

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 1h 35m 42s (16 videos)
ESC 23: The ILUMIEN IV Trial

Ziad A Ali,

Watch time: 4m 12s
ACC.23 Late-Breaker Discussion: The CLEAR-Outcomes Trial

Harriette Van Spall, Steven E Nissen,

Watch time: 16m 12s
ACC 23: Effect of Evolocumab on Coronary Plaque Morphology: The YELLOW III Study

Annapoorna Kini ,

Watch time: 8m 1s
Radcliffe & CardioNerds @AHA22: Reduction of Triglycerides With Pemafibrate

Aruna D Pradhan, Gurleen Kaur,

Watch time: 14m 20s
ESC 2017: The GLAGOV Trial

Stephen J Nicholls,

Watch time: 4m 11s
Transcontinental CHIP Case Sharing Club: CHIP with or without MCS (Mechanical Circulatory Support)

Kevin J. Croce, Eric Eeckhout, Chui Ka-Lung, et al

Watch time: 2h 22m 10s
ACC 22: Magnitude & Duration of Effects of a siRNA Targeting Lp(a)

Steven E Nissen,

Watch time: 3m 31s

Articles

Recurrent Cardiovascular Events Estimation in Indonesian CHD Patients

Dian Sidik Arsyad

,

Steven HJ Hageman

,

Nurul Qalby

,

Ansariadi

,

Wahiduddin

,

Andriany Qanitha

,

Idar Mappangara

,

Pieter AFM Doevendans

,

Frank LJ Visseren

,

Maarten J Cramer

,

Published:

31 August 2023

Citation:

Journal of Asian Pacific Society of Cardiology 2023;2:e33.

DOI:

https://doi.org/10.15420/japsc.2023.04
  • Views: Views 201
  • Downloads: Downloads 11
  • Read time: 18m

Rotatripsy in Left Main Disease

Dinakar Bootla

,

Pruthvi C Revaiah

,

Navjyot Kaur

,

Yash Paul Sharma

,

Himanshu Gupta

,

Published:

25 May 2022

Citation:

Journal of Asian Pacific Society of Cardiology 2022;1:e13.

DOI:

https://doi.org/10.15420/japsc.2021.24
  • Views: Views 1007
  • Downloads: Downloads 32
  • Citations: 1
  • Read time: 11 minutes

Lipoprotein(a) and Cardiovascular Disease

Yoshiyasu Minami

,

Daisuke Kinoshita

,

Yusuke Muramatsu

,

Takako Nagata

,

Junya Ako

,

Published:

13 May 2022

Citation:

Journal of Asian Pacific Society of Cardiology 2022;1:e11.

DOI:

https://doi.org/10.15420/japsc.2021.31
  • Views: Views 1914
  • Downloads: Downloads 71
  • Citations: 1